business investors


Intel (NASDAQ:INTC) has announced its artificial intelligence (AI) strategy in which software will play a bigger role. Chipzilla is aiming to render GPUs irrelevant for running neural networks with the help of software. The company said:

Intel aims to deliver up to 100x reduction in the time to train a deep learning model over the next three years compared to GPU solutions.

Is this Intel’s new marketing strategy to convince AI customers to switch to its processors and FPGAs (field programmable gate arrays) from GPUs of Nvidia (NASDAQ:NVDA), the undisputed leader in AI hardware? This article will delve deeper into the subject.


Click to enlarge

business investors: iShares 20+ Year Treasury Bond (TLT)

Advisors’ Opinion:

  • [By Craig Jones]

    Pravit Chintawongvanich of Macro Risk Advisors spoke on Bloomberg Markets about an options trading idea in iShares Barclays 20+ Yr Treas.Bond (ETF) (NASDAQ: TLT).

  • [By WWW.THESTREET.COM]

    Originally published Nov. 17 at 3:41 p.m. EDT

    The consideration of the contrary has been a theme all week. And here in ” Don’t Run With the Crowd: Embrace the Contrary.”   Miami madness (of a real estate kind)   Mark Grant is scared by our currency’s strength.   Danielle on scenarios.   Boockvar to subscriber Bad Golfer!   JC Penney ( JCP) short puts–a 100% win. (Shorting options frequently ends differently!)   Just say no to closed-end muni-bond funds.   DRYS is all wet.   Could iPhone manufacturing be coming back home?   On inflation breakevens–a picture that speaks volumes.   The market moved higher from the “get go”–in large measure it seems to be a response to the better economic data this morning.   At 3 p.m. stocks were near the day’s highs.   I shorted The Cisco Kid last night. Sticking with this short rental. I added to my ProShares UltraShort S&P500 ETF ( SDS) long (growing ever larger). My net short exposure–is now between small and medium-sized at the close. The US. dollar, as discussed above, continued to rip higher against the euro. I am concerned. Mark Grant is concerned. The market is not concerned. The price of crude oil (down $0.20) settled lower after yesterday’s robust gains. Gold fell $9 as it continues to break down–closing in on $1,200. Ag commodities: wheat up $0.07, corn up $0.04, soybeans up $0.05 and oats up $0.02. Lumber up $7 following the big housing number this morning. Bonds schmeissed . .. iShares Barclays 2

  • [By WWW.THESTREET.COM]

    Investors can trade the U.S. Treasury 30-year bond like a stock using the 20+ Year Treasury Bond ETF (TLT) , which is an ETF backed by a basket of U.S. Treasury bonds with maturities of 20 years to 30 years. As a stock-type investment, it never matures, and interest income is converted to periodic dividend payments.

  • [By Craig Jones]

    On CNBC's Trading Nation, Andrew Keene of AlphaShark spoke about a bearish options strategy in iShares Barclays 20+ Yr Treas.Bond (ETF) (NASDAQ: TLT).

  • [By WWW.THESTREET.COM]

    The Bad

    Bonds behaved poorly. The 10 year and long bond rose by between 3-4 basis points in yield. I bought a trading position in iShares Barclays 20+ Yr Treas.Bond ETF (TLT) in front of a possible yearend pension rebalance. Big pharma stinks up the joint, again. Spec biotech is weakening again (Portola Pharmaceuticals PTLA, ACADIA Pharmaceuticals ACAD, etc.) Retail cant get out of its way. I am long JC Penney (JCP) and have trading positions in Kohl’s (KSS) and Macy’s (M) . (Nike (NKE) , Nordstrom (JWN) , Lowe’s (LOW) are downside features).


    The Ugly

  • [By Craig Jones]

    Todd Gordon spoke on CNBC's Trading Nation about a bullish options strategy in iShares Barclays 20+ Yr Treas.Bond (ETF) (NASDAQ: TLT). He thinks that the ETF could trade higher and he wants to use options to make a bullish bet.

business investors: Tandem Diabetes Care, Inc.(TNDM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares dropped 19 percent to $1.25. Tandem Diabetes Care priced its 18 million share offering at $1.25 per share.

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha) Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha) Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period. Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share. Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement. Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share. Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76. QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share. Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering. Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston
  • [By Paul Ausick]

    Tandem Diabetes Care Inc. (NASDAQ: TNDM) dropped nearly 26% Thursday, to post a new 52-week low of $1.15 after closing at $1.55 on Wednesday. The stock’s 52-week high is $11.30. Volume was more than 20 times the daily average of around 290,000. The company announced an underwritten secondary offering of 18 million shares at $1.25 per share.

business investors: Mechel OAO(MTL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Basic materials shares gained around 1.89 percent in trading on Tuesday. Meanwhile, top gainers in the sector included Olympic Steel, Inc. (NASDAQ: ZEUS), and Mechel PAO (ADR) (NYSE: MTL).

  • [By Lisa Levin]

    Basic materials shares climbed by 2.37 percent in trading on Wednesday. Meanwhile, top gainers in the sector included Handy & Harman Ltd (NYSE: HNH), and Mechel PAO (ADR) (NYSE: MTL).

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 1.10 percent. Meanwhile, top losers in the sector included Mechel PAO (ADR) (NYSE: MTL), down 8 percent, and Eagle Materials, Inc. (NYSE: EXP), down 6 percent.

  • [By Javier Hasse]

    Steel stocks are spiking on Monday afternoon, with AK Steel Holding Corporation (NYSE: AKS) up almost 7.5 percent, United States Steel Corporation (NYSE: X) up about 6.4 percent, Cliffs Natural Resources Inc (NYSE: CLF) up more than 1 percent and Mechel PAO (ADR) (NYSE: MTL) up 16.8 percent. The stocks are not being helped by a few analyst upgrades (although, surely not hurt by them), but seem to be mostly rallying on the back of Donald Trump’s election as president of the United States.

  • [By Shanthi Rexaline]

    Mechel PAO (ADR) (NYSE: MTL) is rallying strongly, rising to a three-year high on roughly 1.7 times its average volume.

    The stock has been on a tear in recent months. After dipping below the $2 level in late April and languishing in the sub-$2 range until August, the stock has nearly tripled in the run up to Monday’s session.

business investors: Barracuda Networks, Inc.(CUDA)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q3 2017 earnings report for small cap security and storage solutions stock Barracuda Networks Inc (NYSE: CUDA) is scheduled for after the market closes onMonday (October 9th) with shares rising 9% the last time around on a good earnings report.

  • [By Lisa Levin]

    Barracuda Networks Inc (NYSE: CUDA) was down, falling around 16 percent to $19.57. Barracuda posted upbeat earnings for its fourth quarter, but issued a disappointing forecast.

  • [By Lisa Levin]

    Barracuda Networks Inc (NYSE: CUDA) reported stronger-than-expected results for its third quarter on Monday.

    Barracuda reported Q3 adjusted earnings of $0.22 per share on revenue of $88.8 million. Analysts were expecting earnings of $0.14 per share on revenue of $86.6 million.

Leave a Reply

Your email address will not be published. Required fields are marked *